课题基金 / 基金详情

项目摘要

项目成果

Richard Schlegel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Worldwide, cervical cancer is the second leading cause of cancer in women and the "high risk" human papillomaviruses play a critical role in the genesis of this malignancy. The papillomaviruses encode two oncoproteins, E6 and E7, that are required for the initiation and maintenance of the malignant state as well as the induction of cell immortalization. Several of these biological activities appear related to the ability of E6 and E7 to degrade the cellular p53 and Rb tumor suppressor proteins, respectively. However, independent of its ability to degrade p53, E6 can induce cellular telomerase activity and, presumably, thereby maintain chromosome telomere length and continued cell proliferation. The rate-limiting event in cellular telomerase activity is the level of hTERT protein, the catalytic subunit of the enzyme complex. We and others have shown that the E6 protein transactivates the hTERT promoter, leading to an increase in hTERT protein and cellular telomerase activity. Our most recent studies indicate that the E6 protein associates with Myc protein and that they both bind and cooperatively activate the hTERT promoter. Interestingly, only the "high risk" E6 proteins bind the hTERT promoter, further supporting the correlation between induction of telomerase and cell immortalization. The current proposal investigates the mechanism by which E6 associates with Myc, binds the hTERT promoter, and facilitates gene transcription. In addition, we will examine whether E6 augments other Myc-regulated genes and whether Myc can mimic a subset of E6-specific cellular phenotypes. The overall goal of the grant is to gain an understanding of the role of E6 in regulating gene transcription, cell growth and cell differentiation.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.ppat.1003284
发表时间: 2013
期刊: PLoS pathogens
影响因子: 6.7
作者: [Miller J, Dakic A, Chen R, Palechor-Ceron N, Dai Y, Kallakury B, Schlegel R, Liu X]
通讯作者: Liu X
Is HPV-18 present in human breast cancer cell lines?
人类乳腺癌细胞系中是否存在 HPV-18?
DOI: 10.1038/sj.bjc.6605671
发表时间: 2010
期刊: British journal of cancer
影响因子: 8.8
作者: [Peran,I, Riegel,A, Dai,Y, Schlegel,R, Liu,X]
通讯作者: Liu,X
Conditionally reprogrammed cells as a novel tool for biobanking
  • 批准号:
    8899468
  • 项目类别:
  • 资助金额:
    $37.88万
  • 财政年份:
    2013
  • 负责人:
    Richard Schlegel
  • 依托单位:
Conditionally reprogrammed cells as a novel tool for biobanking
  • 批准号:
    8727495
  • 项目类别:
  • 资助金额:
    $37.14万
  • 财政年份:
    2013
  • 负责人:
    Richard Schlegel
  • 依托单位:
Conditionally reprogrammed cells as a novel tool for biobanking
  • 批准号:
    8547303
  • 项目类别:
  • 资助金额:
    $40.05万
  • 财政年份:
    2013
  • 负责人:
    Richard Schlegel
  • 依托单位:
Emerging Papillomaviruses in Immunosuppressed Dogs
  • 批准号:
    8516613
  • 项目类别:
  • 资助金额:
    $39.21万
  • 财政年份:
    2011
  • 负责人:
    Richard Schlegel
  • 依托单位:
国内基金
海外基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 项目类别:
    面上项目
  • 资助金额:
    58.00万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    杨迎伍
  • 依托单位: